@Nostockdamus You venture into the wild west of the OTCs. Do you have any thoughts on CYLC? I'm still new to reading and conducting DD on OTC financials. They are in an uptrend since August with solid recent support at .17 and they are releasing a new version of their product this quarter. I don't know if trends and such matter as much in the OTC world but I'm hoping you might shed some light here :D
  • 1
  • 1